Cargando…
Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery
BACKGROUND—: Conflicting results from recent observational studies have raised questions concerning the benefit of β-blockers for patients undergoing coronary artery bypass grafting (CABG). Furthermore, the efficacy of long-term β-blocker therapy in CABG patients after hospital discharge is uncertai...
Autores principales: | Zhang, Heng, Yuan, Xin, Zhang, Haibo, Chen, Sipeng, Zhao, Yan, Hua, Kun, Rao, Chenfei, Wang, Wei, Sun, Hansong, Hu, Shengshou, Zheng, Zhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472324/ https://www.ncbi.nlm.nih.gov/pubmed/25908770 http://dx.doi.org/10.1161/CIRCULATIONAHA.114.014209 |
Ejemplares similares
-
Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021) -
Use of Pulmonary Artery Catheter in Coronary Artery Bypass Graft. Costs and Long-Term Outcomes
por: Xu, Fei, et al.
Publicado: (2015) -
Common Variant in Glycoprotein Ia Increases Long‐Term Adverse Events Risk After Coronary Artery Bypass Graft Surgery
por: Liu, Hanning, et al.
Publicado: (2016) -
The Impact of Body Mass Index on Short- and Long-Term Outcomes in Patients Undergoing Coronary Artery Graft Bypass
por: Ao, Hushan, et al.
Publicado: (2014) -
Comparing Outcomes of Coronary Artery Bypass Grafting Among Large Teaching and Urban Hospitals in China and the United States
por: Zheng, Zhe, et al.
Publicado: (2017)